Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

http://oncologypro.esmo.org/Meeting-Resourc...ess/Treating-breast-cancer-in-pregnant-women

Date: 19 Nov 2017
Presenter: Smruti Koppikar
Resources: Presentation, Webcast
Topics: Cancer in Pregnancy, Breast Cancer, Cancer in Special Situations

http://oncologypro.esmo.org/Meeting-Resourc...Asia-2017-Congress/Preservation-of-fertility

Date: 18 Nov 2017
Presenter: Marc André
Resources: Presentation, Webcast
Topics: Cancer in Adolescents, Complications of Treatment, Cancer in Young Adults, Lymphomas, Cancer in Special Situations, Haematologic Malignancies

http://oncologypro.esmo.org/Meeting-Resourc...-C-virus-Clinical-Features-and-survival-320O

BackgroundIn Egypt, which has a high prevalence of HCV infection, a subset of B-cell non-Hodgkin lymphomas (B-NHL) was linked to HCV infection. HCV infection may affect liver functions causing bad...

Date: 18 Nov 2017
Presenter: Alshimaa Alhanafy
Resources: Abstract, Presentation, Webcast
Topics: Lymphomas, Cancer in Special Situations, Haematologic Malignancies

http://oncologypro.esmo.org/Meeting-Resourc...lly-Resected-Non-Small-Cell-Lung-Cancer-402P

BackgroundThe correlation between severity of lobar emphysema and development of regional lung cancer in individual patient is unclear.MethodsWe measured severity of lobar emphysema using quantitative...

Date: 18 Nov 2017
Presenter: Seung Jun Lee
Resources: Abstract
Topics: Non-Small-Cell Lung Cancer, Early Stage, Cancer in Special Situations

http://oncologypro.esmo.org/Meeting-Resourc...atients-with-non-small-cell-lung-cancer-437P

BackgroundNivolumab (Nivo) demonstrated the promising efficacy for patients with non-small cell lung cancer (NSCLC) as second or later line treatment. However, the efficacy and onset risk of interstitial...

Date: 18 Nov 2017
Presenter: Akihiro Tamiya
Resources: Abstract
Topics: Geriatric Oncology, Non-Small-Cell Lung Cancer, Metastatic, Cancer Immunology and Immunotherapy, Cancer in Special Situations, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...Cancer-Study-Group-Trial-1202-OLCSG1202-455P

BackgroundS-1 is an oral fluoropyrimidine-based combination of tegafur, gimeracil, and oteracil potassium. Although the combination of S-1 with carboplatin is a first-line chemotherapy regimen for...

Date: 18 Nov 2017
Presenter: Akihiro Bessho
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Geriatric Oncology, Non-Small-Cell Lung Cancer, Metastatic, Cancer in Special Situations, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...-old-or-more-retrospective-cohort-study-457P

BackgroundIn elderly patients with advanced non-small cell lung cancer (NSCLC), mono-chemotherapy is the standard treatments such as vinorelbine (VNR) and docetaxel (DOC).

Date: 18 Nov 2017
Presenter: Kanako Katayama
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Geriatric Oncology, Non-Small-Cell Lung Cancer, Metastatic, Cancer in Special Situations, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...reatment-In-Elderly-With-Stage-IV-NSCLC-462P

BackgroundNLR, PLR, LMR and ALI at baseline have been shown to be associated with overall survival (OS) in stage IV non-small cell lung cancer (NSCLC), but the impact of these biomarkers in elderly ≥ 70 years is unknown.

Date: 18 Nov 2017
Presenter: Hiren Mandaliya
Resources: Abstract
Topics: Geriatric Oncology, Non-Small-Cell Lung Cancer, Metastatic, Cancer in Special Situations, Lung and other Thoracic Tumours, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...ositive-Patients-A-Retrospective-Study.-495P

BackgroundThis study aimed to compare the treatment outcomes in AIDS associated cutaneous Kaposi sarcoma, among the patients who received both chemoradiation vs chemotherapy only, in terms of CR, PR, and recurrence rates.

Date: 18 Nov 2017
Presenter: KABILAR VENUGOBAL
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Cancer in Special Situations, AIDS-Associated Malignancies, Melanoma and other Skin Tumours, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...l-cell-lung-cancer-in-elderly-patients.-497P

BackgroundAmrubicin is one of the most active chemotherapeutic agents for small-cell lung cancer (SCLC). Previous studies reported its effectiveness and severe hematological toxicity.

Date: 18 Nov 2017
Presenter: Tomohide Sugiyama
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Small-Cell Lung Cancer, Geriatric Oncology, Cancer in Special Situations, Lung and other Thoracic Tumours